8-KThe WireRoutine
Bylaw Amendment
Filed Jun 10, 2021 · 5y ago · Accession 0001628280-21-012044
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- 8-K
- Filing date
- Jun 10, 2021
- Report date
- Jun 9, 2021
- Document
- tvtx-20210609.htm
- Size
- 195 KB